[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Sdi Group Plc LSE:SDI London Ordinary Share GB00B3FBWW43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 2.5% 205.00 204.00 206.00 205.00 200.00 200.00 76,889 12:40:37
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 35.1 5.6 4.8 42.6 204

Sdi Share Discussion Threads

Showing 1751 to 1772 of 3250 messages
Chat Pages: Latest  82  81  80  79  78  77  76  75  74  73  72  71  Older
DateSubjectAuthorDiscuss
15/4/2019
17:32
52 week high is 53.50
block4gooner
15/4/2019
17:21
Eric - like you I have 1/3 of my holdings in SDI (hold over 0.2% of the company). The others 1/3 are in International Greetings and 1/3 in Future plc - both super companies in their own right which continually under-promise and over-deliver and are delivering superb returns. The connection between the companies - they diversify risk and make very shrewd acquisitions but above all it's top quality MANAGEMENT, MANAGEMENT, MANAGEMENT . As you say- invest in the best and forget the rest (1 bad risky investment wrecks your whole portfolio as I've learnt at great cost over the years). Hastings quick question for you if you don't mind . Ken and Mike are doing superbly well but how long do you think they well stay at the helm/consider retiring (I have no idea how old they are?)
ihatemms
15/4/2019
17:13
Is that an all time high close? Seems to be...
gconvery
15/4/2019
16:26
Interesting to see that Berenberg is now our second largest holder behind BGF, followed by Herald and Octopus.
hastings
15/4/2019
16:21
This is what the CDC say, they and the FDA regarding CWD and CJD are as much use as a chocolate teapot Reprocessing Surgical Instruments Used on Suspected or Confirmed CJD Patients Inactivation studies have not rigorously evaluated the effectiveness of actual cleaning and reprocessing methods used in health care facilities. Recommendations to reprocess instruments potentially contaminated with the CJD agent are primarily derived from in vitro inactivation studies that used either brain tissues or tissue homogenates, both of which pose enormous challenges to any sterilization process. The World Health Organization (WHO) has developed CJD infection control guidelines that can be a valuable guide to infection control personnel and other health care workers involved in the care of CJD patients. Destruction of heat-resistant surgical instruments that come in contact with high infectivity tissues, albeit the safest and most unambiguous method as described in the WHO guidelines, may not be practical or cost effective. One of the three most stringent chemical and autoclave sterilization methods outlined in Annex III of the WHO guidelines (see below) should be used to reprocess heat-resistant instruments that come in contact with high infectivity tissues (brain, spinal cord, and eyes) and low infectivity tissues (cerebrospinal fluid, kidneys, liver, lungs, lymph nodes, spleen, olfactory epithelium, and placenta) of patients with suspected or confirmed CJD. High and low infectivity tissues were defined on the basis of available experimental data as described in Table 2 of the WHO guidelines. The stringent sterilization methods described below should be used to reprocess medical instruments that come in contact with high infectivity tissues of persons known to be blood relatives of patients with inheritable forms of TSEs. In addition, instruments should be kept moist and not allowed to air dry throughout the surgical procedure by immersing them in water or disinfectant solution. Chemical and Autoclave Sterilization Methods Outlined in Annex III of the WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies The three most stringent sterilization methods for heat-resistant instruments described in Annex III of the WHO guidelines are listed below; the methods are listed in order of more to less severe treatments. Sodium hypochlorite may be corrosive to some instruments, such as gold-plated instruments. Before instruments are immersed in sodium hypochlorite, the instrument manufacturer should be consulted about the instrument’s tolerance of exposure to sodium hypochlorite. Instruments should be decontaminated by a combination of the chemical and recommended autoclaving methods before subjecting them to cleaning in a washer cycle and routine sterilization. Immerse in a pan containing 1N sodium hydroxide (NaOH) and heat in a gravity displacement autoclave at 121°C for 30 min; clean; rinse in water; and subject to routine sterilization. [CDC NOTE: The pan containing sodium hydroxide should be covered, and care should be taken to avoid sodium hydroxide spills in the autoclave. To avoid autoclave exposure to gaseous sodium hydroxide condensing on the lid of the container, the use of containers with a rim and lid designed for condensation to collect and drip back into the pan is recommended. Persons who use this procedure should be cautious in handling hot sodium hydroxide solution (post-autoclave) and in avoiding potential exposure to gaseous sodium hydroxide, exercise caution during all sterilization steps, and allow the autoclave, instruments, and solutions to cool down before removal. An experiment Cdc-pdf [PDF – 88KB] conducted by Food and Drug Administration (FDA) investigators indicated that the use of appropriate containment pans and lids prevents escape of sodium hydroxide vapors that may cause damage to the autoclave (Brown and Merritt. Am J Infect Control 2003;31:257-260).] Immerse in 1N NaOH or sodium hypochlorite (20,000 ppm available chlorine) for 1 hour; transfer instruments to water; heat in a gravity displacement autoclave at 121°C for 1 hour; clean; and subject to routine sterilization. [CDC NOTE: Sodium hypochlorite may be corrosive to some instruments.] Immerse in 1N NaOH or sodium hypochlorite (20,000 ppm available chlorine) for 1 hour; remove and rinse in water, and then transfer to open pan and heat in a gravity displacement (121°C) or porous load (134°C) autoclave for 1 hour; clean; and subject to routine sterilization. [CDC NOTE: Sodium hypochlorite may be corrosive to some instruments.] FDA investigators evaluated the effects to surgical instruments of the steps involved in the sterilization protocols listed above; some of the protocols they assessed subjected the instruments to harsher conditions than those prescribed above. Their findings indicate that much of the damage from autoclaving in sodium hydroxide was cosmetic and would not affect the performance or cleaning of the instruments. Soaking in sodium hydroxide had the least damaging effect on instruments, but immersion in sodium hypochlorite bleach caused severe damage to some instruments. The article summarizing the findings of this experiment Cdc-pdf [PDF – 211KB] by Brown et al. of the FDA was published in the Journal of Biomedical Materials Research (electronic version published October 2004). Reprocessing Instruments used in Patients with no Clear Diagnosis of CJD at the Time of Their Neurosurgical Procedure In some patients undergoing neurosurgery, a CJD diagnosis that is not suspected before the procedure may be confirmed after the neurosurgery. For this group of patients, in whom the clinical diagnosis leading to the neurosurgical procedure remains unclear, the instruments should be reprocessed in the same manner as that for instruments used in procedures involving suspected or confirmed CJD patients. Unless a clear non-CJD diagnosis is established, these patients should be considered as potentially suspected CJD patients for all other infection control requirements. Decontaminating Heat-sensitive Instruments or Materials that come in Contact with Suspected or Confirmed CJD Patients All disposable instruments, materials, and wastes that come in contact with high infectivity tissues (brain, spinal cord, and eyes) and low infectivity tissues (cerebrospinal fluid, kidneys, liver, lungs, lymph nodes, spleen, and placenta) of suspected or confirmed TSE patients should be disposed of by incineration. Surfaces and heat-sensitive re-usable instruments that come in contact with high infectivity and low infectivity tissues should be decontaminated by flooding with or soaking in 2N NaOH or undiluted sodium hypochlorite for 1 hour and rinsed with water. [CDC NOTE: Sodium hypochlorite may be corrosive to some instruments.] Precautions for Embalming the Bodies of Patients with Suspected or Confirmed CJD An autopsied or traumatized body of a suspected or confirmed CJD patient can be embalmed, using the precautions outlined in the WHO CJD infection control guidelines External . CJD patients who have not been autopsied or whose bodies have not been traumatized can be embalmed using Standard Precautions. Family members of CJD patients should be advised to avoid superficial contact (such as touching or kissing the patient’s face) with the body of a CJD patient who has been autopsied. However, if the patient has not been autopsied, such contact need not be discouraged. The WHO in 2003 also did a gloss over of the problem hTtps://www.who.int/csr/resources/publications/bse/whocdscsraph2003.pdf
buywell3
15/4/2019
16:04
What do you care you sold out of sdi ages ago to put it into OIL stocks like HUR and SIA Get back to your greasy mates The CDC site is out of date very poor data for as government site If you took the trouble to read buywells posts he says that ALL governments and agencies are trying to keep folks in the dark to stop panic
buywell3
15/4/2019
13:01
Look at the site for the US Centres for Disease Control and Prevention hxxps://www.cdc.gov/prions/index.html If they are right, and they should be about the most reliable source, the issues relating to prion diseases are a lot smaller than many are suggesting. They do show an increase in CJD over the past past 40 years, in the US of around 4-500%. However, while that looks significant, when they adjust for increased population age the increase is much smaller, around 10-20%. Most of the increase is due to increase in population age, and the fact that most CJD cases occur in elderly patients. For vCJD they record only 4 cases ever in the US, all with clear links to other countries, the UK mostly, where it was assumed to have been picked up. On CWD, while there is certainly an increase in occurrence, they have introduced measures similar to the UK during BSE, limiting consumption of the riskiest parts of the animals, and there are no known cases of transmission from cervids to humans. Overall, while Proreveal is undoubtedly a useful bit of kit, which may find a useful market, large increases in prion related disease, in the US or elsewhere does not currently seem likely to have much impact on sales.
greyingsurfer
15/4/2019
11:05
On another thread in 2017 I said this ..... buywell312 Jul '17 - 07:40 - 19 of 19 Edit buywell predicts many more accretive acquisitions to come in the next 3 years Profits to rise to 4 Million GBP Share price to hit 50p in 2019 and 60p in 2020 Scientific Digital Imaging to get acquired itself for 85p in 2021 Trading Update The Board of Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets, is pleased to announce an update on trading for the 12 month period ended 30 April 2017. Reported profits before tax are expected to be in line with management's expectations, with the latest acquisition, Astles Control Systems, as expected making a contribution to the profits of the Group. Ken Ford, Chairman of SDI, commented: "We have once again strengthened the Group with the recent acquisition and are pleased with the positive contribution from Astles Control Systems. This is a business model we plan to continue to replicate in order to grow a diversified company with increasing revenue streams." The final results for the year ended 30 April 2017 will be released in July 2017. https://uk.advfn.com/cmn/fbb/thread.php3?id=24016630 That's the link above 50p hit as predicted .... 60p plus soon as predicted Who else predicted this on this thread ?
buywell3
15/4/2019
10:41
Excellent thank you for the response
ronwilkes123
15/4/2019
10:31
buywell * n, do you not think your campaign to raise awareness would be more effective if it was aimed at your MP or the NHS rather than clogging up this BB?
alter ego
15/4/2019
10:27
16.5x FY21 being 3.75p EPS is a base case IMO excluding any wide market meltdown which gives the 62p. I think there's scope for both of those numbers to move up (18x 3.9p is suddenly 70p) so it's a completely rolling target, but given I want to own this for the foreseeable future, it's kind of arbitrary. M&A also adds on top of those. But that 62p is almost what I see as 3-6 months base case fair value When I scan the SMID cap space in the UK for companies under £100m, there are few of quality, which have solid ebit margins and an attractive industry to operate in. There is a real scarcity value to small cap quality plays, not least those with real compounding potential. Last point - free cash flow conversion is really underrated by retail investors IMO. So many companies on 15-20x P/E end up being on 25 -30x free cash flow because they are maintenance capex heavy or have issues around working capital. Those businesses, like JDG and SDI which consistently convert EBIT into high free cash flow should trade at a premium. They do in the large cap space, but not yet twigged by small cap investors
pireric
15/4/2019
10:19
This is a must listened to link below , here is why What buywell2 has been talking about recently regarding Alzheimer's and Parkinson's being prion diseases is explained further. It seems that ANY misfolded protein ie a bad protein , that is mentioned in this link in connection with that particular disease , IF left on a surgical instrument as MISFOLDED protein residue, would possess the ability to transmit that disease to another individual. Which would suggest that the DOH should look at widening their scope regarding the testing for protein residues on ALL surgical instruments as most diseases mentioned in the following link are becoming widespread and the people with them having operations at NHS Hospitals. hTtps://www.youtube.com/watch?v=pxZmJ_TkUjU
buywell3
15/4/2019
10:13
What's your target price based on your analysis Eric - I've seen you say north of 62p this year on twitter
ronwilkes123
15/4/2019
10:05
Apologies Eric, just seen and replied now.
hastings
15/4/2019
09:58
Great post Hastings (p.s. I private messaged you on here) Will try my best Ed, but as the biggest position of mine by far, I don't have much excuse not to! Again, if anyone has any suggestions for modelling etc to do then let me know
pireric
15/4/2019
09:52
Thankyou for the table Eric. Agree with your POV. Please post more.
edscoville
15/4/2019
08:33
Cheers for the table pireric
owenski
15/4/2019
08:31
Fair do's buywell. Hope you're right on ProReveal but I think you're definitely right in thinking the market isn't giving credit at the moment as I think most investors have discounted it. Will try and mock up another graphic for Easter Monday of some sort There's an argument to say #JDG and #SDI should trade at premium multiples (18x+), as if they execute, then you effectively get 1-5+ 'ahead of expectations' per year via M&A, generally adding 3-8% to run-rate EPS each time.
pireric
13/4/2019
15:49
Very helpful. Thx.
alter ego
13/4/2019
12:51
Super stuff Eric.
hastings
13/4/2019
12:03
Have posted this graphic elsewhere, but haven't done so here for a while. Updated SDI historics and forecasts table. Pretty busy next week but any analysis you guys want done I can try to do over the coming weeks.
pireric
13/4/2019
11:50
More from you Eric !
glaws2
Chat Pages: Latest  82  81  80  79  78  77  76  75  74  73  72  71  Older
ADVFN Advertorial
Your Recent History
LSE
SDI
Sdi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210923 12:03:39